Mylab Discovery Solutions, a molecular biology company developing and commercialising human diagnostic tests, has announced that it can produce 100 million units of its at-home Covid-19 test kits every week over the next few months, depending on demand. While the use of at-home tests is not prevalent in India, the Mylab test kit is the first to have received such approval as the country struggles to battle the third wave of infections.
US-based rapid Covid-19 tests developer Megna Health announced that it has filed an application for the extension of its Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for the prescription home use of its rapid Covid-19 IgG/IgM antibody test. The easy-to-use product can give a result within 15 minutes using a drop of fingerstick sample.
Quidel Corporation has announced that Health Canada has approved its Sofia SARS Antigen FIA test. It is the first rapid antigen test to receive authorisation in the country for serial testing that will help detect SARS-CoV-2 infection in both symptomatic and asymptomatic individuals.